SBP solbec pharmaceuticals limited

Progen (ASX:PGL) announced today that their lead...

  1. keith bogucki
    40 Posts.
    clock Created with Sketch.
    04/05/04
    16:14
    Post #: 456790
    Progen (ASX:PGL) announced today that their lead anti-angiogenesis product (PI-88) has received Orphan Drug designation from the US FDA.

    Will be interesting to see the effect on Solbec & chances of gaining orphan drug status also.
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.